Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice

gan Melariri, Paula, Kalombo, Lonji, Nkuna, Patric, Dube, Admire, Hayeshi, Rose, Ogutu, Benhards, Gibhard, Liezl, deKock, Carmen, Smith, Peter, Wiesner, Lubbe, Swai, Hulda
Cyhoeddwyd yn Int J Nanomedicine (2015)

Spray-Dried, Nanoencapsulated, Multi-Drug Anti-Tuberculosis Therapy Aimed at Once Weekly Administration for the Duration of Treatment

gan Kalombo, Lonji, Lemmer, Yolandy, Semete-Makokotlela, Boitumelo, Ramalapa, Bathabile, Nkuna, Patric, Booysen, Laetitia L.L.I.J., Naidoo, Saloshnee, Hayeshi, Rose, Verschoor, Jan A., Swai, Hulda S.
Cyhoeddwyd yn Nanomaterials (Basel) (2019)